EUVIMEDEUVIMED entdecken
Crossref

Allogeneic transplantation for adult T‐cell leukemia/lymphoma in adolescent and young adults and young patients: A nationwide retrospective study by the ATL working group of the Japan society for transplantation and cellular therapy

Hidehiro Itonaga, Takuya Fukushima, Koji Kato, Nobuaki Nakano, Takeharu Kato, Takashi Tanaka, Tetsuya Eto, Yasuo Mori, Toshiro Kawakita, Naoyuki Uchida, Machiko Fujioka iD, Hirohisa Nakamae und 7 weitere

Hematological Oncology · 2024

DOI: 10.1002/hon.3315 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hematological Oncology, 2024. Verfasst von Hidehiro Itonaga und 18 weiteren Autor:innen. Beteiligte Einrichtung: Transfusion and Cell Therapy Unit, Nagasaki University Hospital, Nagasaki, Japan. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Leukemia-Lymphoma, Adult T-Cell, Transplantation, Homologous, Graft vs Host Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Takeda Science Foundation, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Allogeneic hematopoietic stem cell transplantation (allo‐HSCT) provides durable remission for patients with adult T‐cell leukemia/lymphoma (ATL); however, few studies have focused on post‐transplant outcomes in ATL patients ≤49 years. To clarify prognostic factors in ATL among patients

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationLeukemia-Lymphoma, Adult T-CellTransplantation, HomologousGraft vs Host DiseaseHumansMaleAdultFemaleRetrospective StudiesAdolescentYoung AdultMiddle AgedJapanTransplantation ConditioningSurvival RatePrognosis

Stichwörter der Autor:innen

adolescent and youngadult T‐cell leukemia/lymphomaallogeneic hematopoietic stem cell transplantation

Autor:innen und Institutionen

  • Transfusion and Cell Therapy Unit, Nagasaki University Hospital, Nagasaki, Japan.
  • Laboratory of Hematoimmunology, Graduate School of Health Sciences, University of the Ryukyus, Nishihara, Japan.
  • Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
  • Department of Hematology, Imamura General Hospital, Kagoshima, Japan.
  • Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan.
  • Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.

ORCID-Profile: Machiko Fujioka, Yoshinobu Kanda

Förderung

  • Takeda Science Foundation
  • Japan Society for the Promotion of Science

Zitieren

APA

Itonaga, H., Fukushima, T., Kato, K., Nakano, N., Kato, T., Tanaka, T., Eto, T., Mori, Y., Kawakita, T., Uchida, N., Fujioka, M., Nakamae, H., Ogata, M., Morishima, S., Fukuda, T., Kanda, Y., Atsuta, Y., Fuji, S., & Yoshimitsu, M. (2024). Allogeneic transplantation for adult T‐cell leukemia/lymphoma in adolescent and young adults and young patients: A nationwide retrospective study by the ATL working group of the Japan society for transplantation and cellular therapy. Hematological Oncology. https://doi.org/10.1002/hon.3315

Vancouver

Itonaga H, Fukushima T, Kato K, Nakano N, Kato T, Tanaka T, et al. Allogeneic transplantation for adult T‐cell leukemia/lymphoma in adolescent and young adults and young patients: A nationwide retrospective study by the ATL working group of the Japan society for transplantation and cellular therapy. Hematological Oncology. 2024. doi:10.1002/hon.3315

BibTeX
@article{Itonaga2024,
  author = {Itonaga, Hidehiro and Fukushima, Takuya and Kato, Koji and Nakano, Nobuaki and Kato, Takeharu and Tanaka, Takashi and Eto, Tetsuya and Mori, Yasuo and Kawakita, Toshiro and Uchida, Naoyuki and Fujioka, Machiko and Nakamae, Hirohisa and Ogata, Masao and Morishima, Satoko and Fukuda, Takahiro and Kanda, Yoshinobu and Atsuta, Yoshiko and Fuji, Shigeo and Yoshimitsu, Makoto},
  title = {Allogeneic transplantation for adult T‐cell leukemia/lymphoma in adolescent and young adults and young patients: A nationwide retrospective study by the ATL working group of the Japan society for transplantation and cellular therapy},
  journal = {Hematological Oncology},
  year = {2024},
  doi = {10.1002/hon.3315}
}
Kostenlos starten →